Page 28 - AN-1-3

Advanced Neurology Early inhibition of PDK1 prevents AD-like pathology

learning and memory. Mol Psychiatry: s41380-022-01579-7. 51. Hay N, Sonenberg N, 2004, Upstream and downstream of
mTOR. Genes Dev, 18: 1926–1945.
42. Peng SX, Wang YY, Zhang M, et al., 2021, SNP rs10420324
in the AMPA receptor auxiliary subunit TARP g-8 regulates 52. Kimberly WT, LaVoie MJ, Ostaszewski BL, et al., 2003,
the susceptibility to antisocial personality disorder. Sci Rep, Gamma-secretase is a membrane protein complex
11: 11997. comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc
43. Xia Y, Zhang Y, Xu M, et al., 2022, Presenilin enhancer2 Natl Acad Sci USA, 100: 6382–6387.
is crucial for the transition of apical progenitors into 53. De Strooper B, Karran E, 2016, The cellular phase of
neurons but into not basal progenitors in the developing Alzheimer’s disease. Cell, 164: 603–615.
hippocampus. Development, 149: dev200272.
54. Anguela XM, High KA, 2019, Entering the modern era of
44. Teng X, Hu P, Chen Y, et al., 2022, A novel Lgi1 mutation gene therapy. Ann Rev Med, 70: 273–288.
causes white matter abnormalities and impairs motor
coordination in mice. FASEB J, 36: e22212. 55. Mendell JR, Al-Zaidy S, Shell R, et al., 2017, Single-dose
gene-replacement therapy for spinal muscular atrophy.
45. Hou J, Bi H, Ye Z, et al., 2021, Pen-2 negatively regulates the N Engl J Med, 377: 1713–1722.
differentiation of oligodendrocyte precursor cells into astrocytes
in the central nervous system. J Neurosci, 41: 4976–4990. 56. Thomsen GM, Gowing G, Latter J, et al., 2014, Delayed
disease onset and extended survival in the SOD1G93A rat
46. Bi H, Zhou C, Zhang Y, et al., 2021, Neuron-specific deletion model of amyotrophic lateral sclerosis after suppression of
of presenilin enhancer2 causes progressive astrogliosis and mutant SOD1 in the motor cortex. J Neurosci, 34: 15587.
age-related neurodegeneration in the cortex independent of
the Notch signaling. CNS Neurosci Ther, 27: 174–185. 57. McBride JL, Pitzer MR, Boudreau RL, et al., 2011, Preclinical
safety of RNAi-mediated HTT suppression in the rhesus
47. Hou J, Bi H, Ge Q, et al., 2022, Heterogeneity analysis macaque as a potential therapy for Huntington’s disease. Mol
of astrocytes following spinal cord injury at single-cell Ther, 19: 2152–2162.
resolution. FASEB J, 36: e22442.
58. Duan YY, Ye T, Qu Z, et al., 2022, Brain-wide Cas9-mediated
48. Saura CA, Chen G, Malkani S, et al., 2005, Conditional cleavage of a gene causing familial Alzheimer’s disease
inactivation of presenilin 1 prevents amyloid accumulation alleviates amyloid-related pathologies in mice. Nat Biomed
and temporarily rescues contextual and spatial working Eng, 6: 168–180.
memory impairments in amyloid precursor protein
transgenic mice. J Neurosci, 25: 6755–6764. 59. Peifer C, Alessi DR, 2008, Small molecule inhibitors of
PDK1. ChemMedChem, 3: 1810–1838.
49. Lai KO, Liang ZY, Fei EK, et al., 2015, Cyclin-dependent
kinase 5 (Cdk5)-dependent phosphorylation of p70 60. Bain J, Plater L, Elliott M, et al., 2007, The selectivity of
ribosomal S6 kinase 1 (S6K) is required for dendritic spine protein kinase inhibitors: A further update. Biochem J,
morphogenesis. J Biol Chem, 290: 14637–14646. 408: 297–315.
50. Ruvinsky I, Meyuhas O, 2006, Ribosomal protein S6 61. Pelletier J, Thomas G, Volarević S, 2018, Ribosome
phosphorylation: From protein synthesis to cell size. Trends biogenesis in cancer: New players and therapeutic avenues.
Biochem Sci, 31: 342–348. Nat Rev Cancer, 18: 51–63.

Volume 1 Issue 3 (2022) 12 https://doi.org/10.36922/an.v1i3.153